Skip to main content
. Author manuscript; available in PMC: 2012 Sep 24.
Published in final edited form as: Am J Transplant. 2011 Jan;11(1):45–55. doi: 10.1111/j.1600-6143.2010.03365.x

Table 3.

Ganciclovir (20mg/kg/day for 30 days) slows RCMV-accelerated TVS inallografts from acutely infected recipients (ARI) but not in allografts from latently infected donors (LDI).

Group n= Infection
Day		 POD Histological
Presentation		 Neoinimal Index
(TVS)+/−SD
LDI 8 −180 54 Chronic Rejection 63+/−7
LDI+Ganciclovir 6 −180 52 Chronic Rejection 65+/−3
ARI 6 1 43 Chronic Rejection 80+/−5
ARI+Ganciclovir 6 1 75* Chronic Rejection 65+/−4**
*

vs. POD ARI p<0.001,

**

vs. ARI NI p<0.001